- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Patent holdings for IPC class A61K 45/06
Total number of patents in this class: 43786
10-year publication summary
|
4142
|
4173
|
4506
|
4337
|
4583
|
4877
|
4368
|
3878
|
3728
|
1458
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10975 |
598 |
| The Regents of the University of California | 19780 |
455 |
| Merck Sharp & Dohme LLC | 3726 |
339 |
| Genentech, Inc. | 3927 |
313 |
| Board of Regents, The University of Texas System | 5736 |
312 |
| Bristol-myers Squibb Company | 4897 |
297 |
| Dana-Farber Cancer Institute, Inc. | 2545 |
294 |
| Gilead Sciences, Inc. | 2019 |
288 |
| Boehringer Ingelheim International GmbH | 4705 |
268 |
| The Johns Hopkins University | 5626 |
224 |
| Regeneron Pharmaceuticals, Inc. | 4201 |
212 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3357 |
209 |
| The Board of Trustees of the Leland Stanford Junior University | 6322 |
207 |
| Emory University | 1619 |
199 |
| The General Hospital Corporation | 4695 |
194 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
186 |
| Pfizer Inc. | 3355 |
183 |
| Centre National de La Recherche Scientifique | 10266 |
178 |
| Yale University | 2347 |
176 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2732 |
168 |
| Other owners | 38486 |